• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

China cardiovascular diseases report 2015: a summary.

作者信息

Chen Wei-Wei, Gao Run-Lin, Liu Li-Sheng, Zhu Man-Lu, Wang Wen, Wang Yong-Jun, Wu Zhao-Su, Li Hui-Jun, Gu Dong-Feng, Yang Yue-Jin, Zheng Zhe, Jiang Li-Xin, Hu Sheng-Shou

机构信息

National Center for Cardiovascular Diseases, Beijing, China.

Beijing Tiantan Hospital, Beijing, China.

出版信息

J Geriatr Cardiol. 2017 Jan;14(1):1-10. doi: 10.11909/j.issn.1671-5411.2017.01.012.

DOI:10.11909/j.issn.1671-5411.2017.01.012
PMID:28270835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5329726/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/7dde1f7fc2a2/jgc-14-01-001-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/f0d3de7b126d/jgc-14-01-001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/51c11e9527fb/jgc-14-01-001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/ec3c1f20c269/jgc-14-01-001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/4e3f7b80d623/jgc-14-01-001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/f80c5e66e193/jgc-14-01-001-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/4215872b557d/jgc-14-01-001-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/7dde1f7fc2a2/jgc-14-01-001-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/f0d3de7b126d/jgc-14-01-001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/51c11e9527fb/jgc-14-01-001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/ec3c1f20c269/jgc-14-01-001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/4e3f7b80d623/jgc-14-01-001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/f80c5e66e193/jgc-14-01-001-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/4215872b557d/jgc-14-01-001-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdf5/5329726/7dde1f7fc2a2/jgc-14-01-001-g007.jpg

相似文献

1
China cardiovascular diseases report 2015: a summary.《2015年中国心血管病报告：概要》
J Geriatr Cardiol. 2017 Jan;14(1):1-10. doi: 10.11909/j.issn.1671-5411.2017.01.012.
2
[The impact of hypertension history and baseline blood pressure levels on the cardiovascular outcomes in Chinese emergency atrial fibrillation patients].[高血压病史和基线血压水平对中国急诊房颤患者心血管结局的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Nov;41(11):911-5.
3
Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study.中国心房颤动卒中患者的口服抗凝治疗应用：中国 QUEST（卒中护理和治疗质量评估）登记研究。
Int J Stroke. 2013 Apr;8(3):150-4. doi: 10.1111/j.1747-4949.2011.00716.x. Epub 2011 Dec 14.
4
The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry.使用中国心房颤动注册研究（China-AF）的数据评估非瓣膜性心房颤动患者抗心律失常药物的使用与患者预后的关系。
Med Sci Monit. 2019 Jun 30;25:4856-4868. doi: 10.12659/MSM.916855.
5
Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China.中国大陆住院房颤患者的回顾性调查。
Int J Cardiol. 2005 Dec 7;105(3):283-7. doi: 10.1016/j.ijcard.2004.12.042.
6
Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.中国心房颤动患者基于证据的他汀类药物治疗的应用情况：中国心房颤动注册研究（CAFR）报告
Int J Cardiol. 2016 Oct 1;220:284-9. doi: 10.1016/j.ijcard.2016.06.113. Epub 2016 Jun 23.
7
[Impact of history of hypertension and blood pressure levels on the risk of thromboembolism in nonvalvular atrial fibrillation patients].[高血压病史和血压水平对非瓣膜性心房颤动患者血栓栓塞风险的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Sep 24;48(9):721-727. doi: 10.3760/cma.j.cn112148-20200713-00552.
8
[Risk factors for stroke in Chinese with non valvular atrial fibrillation: a case-control study].[中国非瓣膜性心房颤动患者卒中的危险因素：一项病例对照研究]
Zhonghua Nei Ke Za Zhi. 2003 Mar;42(3):157-61.
9
Differences in stroke risk and cardiovascular mortality for Aboriginal and other Australian patients with atrial fibrillation.澳大利亚原住民和其他族裔心房颤动患者的中风风险和心血管死亡率差异。
Med J Aust. 2020 Mar;212(5):215-221. doi: 10.5694/mja2.50496. Epub 2020 Feb 6.
10
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.在伴有心血管疾病的不耐受血管紧张素转化酶抑制剂患者中进行的替米沙坦单独治疗与替米沙坦联合雷米普利全球终点试验/替米沙坦随机评估研究中的高心血管风险患者中，血压和其他新发性心房颤动决定因素。
J Hypertens. 2012 May;30(5):1004-14. doi: 10.1097/HJH.0b013e3283522a51.

引用本文的文献

1
Novel biomarkers of the Framingham risk score in patients with depression: A cross-sectional study.抑郁症患者中弗雷明汉姆风险评分的新型生物标志物：一项横断面研究。
World J Psychiatry. 2025 Aug 19;15(8):106303. doi: 10.5498/wjp.v15.i8.106303.
2
Comparison of treatment patterns, efficacy and safety between generic and branded atorvastatin users in China: a multicenter, retrospective propensity score-matched cohort study.中国仿制药与原研阿托伐他汀使用者的治疗模式、疗效及安全性比较：一项多中心、回顾性倾向评分匹配队列研究
Lipids Health Dis. 2025 Jul 22;24(1):248. doi: 10.1186/s12944-025-02673-9.
3
Impacts of Household Solid Fuel Combustion on Blood Pressure: Mechanisms and Implications.

本文引用的文献

1
Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry.中国接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的症状发作至球囊扩张时间、ST段回落情况及院内死亡率：来自中国急性心肌梗死注册研究
Am J Cardiol. 2016 Nov 1;118(9):1334-1339. doi: 10.1016/j.amjcard.2016.07.058. Epub 2016 Aug 13.
2
Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes.氯吡格雷联合阿司匹林治疗急性小卒中或短暂性脑缺血发作（CHANCE）试验：一年结果。
Circulation. 2015 Jul 7;132(1):40-6. doi: 10.1161/CIRCULATIONAHA.114.014791. Epub 2015 May 8.
3
家庭固体燃料燃烧对血压的影响：机制与启示
Environ Health (Wash). 2025 Jan 22;3(5):458-468. doi: 10.1021/envhealth.4c00182. eCollection 2025 May 16.
4
Association between TyG index with obesity indicators and coronary heart disease: a cohort study.甘油三酯与葡萄糖指数（TyG指数）与肥胖指标及冠心病之间的关联：一项队列研究。
Sci Rep. 2025 Mar 14;15(1):8920. doi: 10.1038/s41598-025-93922-5.
5
Risk variables of heart failure among patients in China: grey relational approach based multi-dimensional assessment study.中国患者心力衰竭的风险变量：基于灰色关联法的多维度评估研究
Diabetol Metab Syndr. 2024 Aug 23;16(1):205. doi: 10.1186/s13098-024-01445-2.
6
Can physical activity counteract the negative effects of sedentary behavior on the physical and mental health of children and adolescents? A narrative review.体育运动能否抵消久坐行为对儿童和青少年身心健康的负面影响？一项叙述性综述。
Front Public Health. 2024 Aug 2;12:1412389. doi: 10.3389/fpubh.2024.1412389. eCollection 2024.
7
NHHR: An Important Independent Risk Factor for Patients with STEMI.NHHR：ST段抬高型心肌梗死患者的一个重要独立危险因素。
Rev Cardiovasc Med. 2022 Dec 9;23(12):398. doi: 10.31083/j.rcm2312398. eCollection 2022 Dec.
8
Can an intervention integrating sports and medicine improve children's health more effectively? Monitoring based on sleep, body mass index, and heart rate variability.运动与医学整合干预能否更有效地改善儿童健康？基于睡眠、体重指数和心率变异性的监测。
J Glob Health. 2024 Apr 19;14:04040. doi: 10.7189/jogh.14.04040.
9
China's carbon-neutral policies will reduce short-term PM-associated excess incidence of cardiovascular diseases.中国的碳中和政策将减少短期与细颗粒物相关的心血管疾病额外发病率。
One Earth. 2024 Mar 15;7(3):497-505. doi: 10.1016/j.oneear.2024.01.006.
10
Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities: The DECIDE-Salt Cluster Randomized Clinical Trial.养老机构用盐替代品和盐供应限制的成本效益：DECIDE-Salt 盐簇随机临床试验。
JAMA Netw Open. 2024 Feb 5;7(2):e2355564. doi: 10.1001/jamanetworkopen.2023.55564.
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.中国高血压人群脑卒中一级预防中叶酸治疗的疗效：CSPPT 随机临床试验。
JAMA. 2015 Apr 7;313(13):1325-35. doi: 10.1001/jama.2015.2274.
4
Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality.细颗粒物空气污染与缺血性心脏病发病率和死亡率之间的关系。
Heart. 2015 Feb;101(4):257-63. doi: 10.1136/heartjnl-2014-306165. Epub 2014 Oct 23.
5
Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).中国代谢综合征患者的降脂治疗与血脂达标情况：血脂异常国际研究中国项目（DYSIS-China）的亚组分析
Atherosclerosis. 2014 Nov;237(1):99-105. doi: 10.1016/j.atherosclerosis.2014.08.023. Epub 2014 Sep 1.
6
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data.2001年至2011年中国ST段抬高型心肌梗死（中国PEACE-急性心肌梗死回顾性研究）：医院数据的回顾性分析
Lancet. 2015 Jan 31;385(9966):441-51. doi: 10.1016/S0140-6736(14)60921-1. Epub 2014 Jun 23.
7
Trends in incidence of hypertension in Chinese adults, 1991-2009: the China Health and Nutrition Survey.1991 - 2009年中国成年人高血压发病率趋势：中国健康与营养调查
Int J Cardiol. 2014 Jul 15;175(1):96-101. doi: 10.1016/j.ijcard.2014.04.258. Epub 2014 May 2.
8
Sex differences in trends of incidence and mortality of first-ever stroke in rural Tianjin, China, from 1992 to 2012.中国天津农村地区 1992 年至 2012 年首次脑卒中发病率和死亡率的性别趋势差异。
Stroke. 2014 Jun;45(6):1626-31. doi: 10.1161/STROKEAHA.113.003899. Epub 2014 Apr 15.
9
Prevalence and control of diabetes in Chinese adults.中国成年人糖尿病的患病率和控制情况。
JAMA. 2013 Sep 4;310(9):948-59. doi: 10.1001/jama.2013.168118.
10
Prevalence of chronic kidney disease in China: a cross-sectional survey.中国慢性肾脏病患病率的横断面调查。
Lancet. 2012 Mar 3;379(9818):815-22. doi: 10.1016/S0140-6736(12)60033-6.